Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.
MainStay Epoch US Equity Yield Investor EPLIX
- NAV / 1-Day Return 20.02 / −0.15 %
- Total Assets 961.8 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.330%
- Distribution Fee Level High
- Share Class Type Front Load
- Category Large Value
- Investment Style Large Value
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 1.73%
- Turnover 19%
USD | NAV as of Apr 17, 2024 | 1-Day Return as of Apr 17, 2024, 10:05 PM GMT+0
Morningstar’s Analysis EPLIX
Will EPLIX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 21.0
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
JPMorgan Chase & Co | 2.53 | 25.6 Mil | Financial Services |
Bank of America Corp | 2.32 | 23.4 Mil | Financial Services |
Eli Lilly and Co | 2.26 | 22.9 Mil | Healthcare |
Broadcom Inc | 2.22 | 22.4 Mil | Technology |
MetLife Inc | 2.21 | 22.4 Mil | Financial Services |
AbbVie Inc | 2.09 | 21.1 Mil | Healthcare |
Cummins Inc | 2.04 | 20.6 Mil | Industrials |
Merck & Co Inc | 2.01 | 20.4 Mil | Healthcare |
UnitedHealth Group Inc | 1.68 | 17.0 Mil | Healthcare |
Iron Mountain Inc | 1.67 | 16.9 Mil | Real Estate |